BGC Stock Analysis: BGC | NASDAQ
Capital Markets | NASDAQ, USA | Market Cap: 5.325m USD | 12M Return: 21.2% | US0889291045 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.8M
EPS Trend: 99.6%
Qual. Beats: 1
Rev. Trend: 97.1%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BGC Group, Inc. is a financial brokerage and technology company listed on NASDAQ, operating across the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company is classified within the Financials sector, specifically the Investment Banking & Brokerage subsector, reflecting its core role as an intermediary in capital and commodities markets.
Its brokerage operations span a wide range of asset classes, including government and corporate bonds, interest rate and credit derivatives, foreign exchange, fixed income, equities, futures and options, listed derivatives, and physical commodities in oil, refined products, environmental, and energy transition markets. The company also provides ship chartering services. In addition, BGC offers post-trade and infrastructure services such as clearing, market data, network and connectivity solutions, and financial technology products.
BGC serves a diverse institutional client base, including banks, broker-dealers, trading firms, hedge funds, governments, corporations, investment firms, commodity trading firms, and end users, supporting transactions executed both over-the-counter and on exchanges through its integrated platform. The company was founded in 1945 and is headquartered in New York, New York.
- Fenics electronic platform growth expands high-margin revenue mix
- Rate volatility drives fixed income and FX brokerage volumes
- Special dividends and buybacks boost shareholder capital returns
| Net Income: 198.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.09 > 1.0 |
| NWC/Revenue: -23.09% < 20% (prev 46.02%; Δ -69.11% < -1%) |
| CFO/TA 0.08 > 3% & CFO 447.7m > Net Income 198.9m |
| Net Debt (1.09b) to EBITDA (511.6m): 2.13 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (479.1m) vs 12m ago -1.14% < -2% |
| Gross Margin: 79.98% > 18% (prev 43.56%; Δ 36.42% > 0.5%) |
| Asset Turnover: 63.27% > 50% (prev 51.62%; Δ 11.65% > 0%) |
| Interest Coverage Ratio: 3.07 > 6 (EBIT TTM 405.0m / Interest Expense TTM 132.1m) |
| A: -0.14 (Total Current Assets 3.70b - Total Current Liabilities 4.48b) / Total Assets 5.75b |
| B: -0.13 (Retained Earnings -773.1m / Total Assets 5.75b) |
| C: 0.08 (EBIT TTM 405.0m / Avg Total Assets 5.32b) |
| D: 0.25 (Book Value of Equity 1.11b / Total Liabilities 4.48b) |
| Altman-Z'' = -0.55 = B |
| DSRI: 1.08 (Receivables 2.82b/1.96b, Revenue 3.37b/2.53b) |
| GMI: 0.54 (GM 43.56% / 79.98%) |
| AQI: 0.84 (AQ_t 0.33 / AQ_t-1 0.39) |
| SGI: 1.33 (Revenue 3.37b / 2.53b) |
| TATA: -0.04 (NI 198.9m - CFO 447.7m) / TA 5.75b) |
| Beneish M = -3.23 (Cap -4..+1) = AA |
As of August 22, 2026, the stock is trading at USD 11.85 with a total of 4,563,899 shares traded. Over the past week, the price has changed by +5.99%, over one month by +4.59%, over three months by +6.86% and over the past year by +21.16%.
Current recommended Stop Loss: 11.10 (which is 6.3% or 2 ATR below the current price).
BGC has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy BGC.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 15.5 | 30.8% |
P/E Trailing = 28.0
P/E Forward = 5.9382
P/S = 1.6841
P/B = 4.8211
P/EG = 3.5958
Revenue TTM = 3.37b USD
EBIT TTM = 405.0m USD
EBITDA TTM = 511.6m USD
Long Term Debt = 1.54b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.77b USD (from shortTermDebt, last quarter)
Debt = 1.97b USD (from shortLongTermDebtTotal, last quarter) + Leases 197.0m
Net Debt = 1.09b USD (calculated: Debt 1.97b - CCE 881.1m)
Enterprise Value = 6.42b USD (5.33b + Debt 1.97b - CCE 881.1m)
Interest Coverage Ratio = 3.07 (Ebit TTM 405.0m / Interest Expense TTM 132.1m)
EV/FCF = 16.04x (Enterprise Value 6.42b / FCF TTM 399.8m)
FCF Yield = 6.23% (FCF TTM 399.8m / Enterprise Value 6.42b)
FCF Margin = 11.88% (FCF TTM 399.8m / Revenue TTM 3.37b)
Net Margin = 5.91% (Net Income TTM 198.9m / Revenue TTM 3.37b)
Gross Margin = 79.98% ((Revenue TTM 3.37b - Cost of Revenue TTM 674.0m) / Revenue TTM)
Gross Margin QoQ = 90.61% (prev 91.50%)
Tobins Q-Ratio = 1.12 (Enterprise Value 6.42b / Total Assets 5.75b)
Interest Expense / Debt = 6.70% (Interest Expense 132.1m / Debt 1.97b)
Taxrate = 30.67% (83.7m / 272.9m)
NOPAT = 280.8m (EBIT 405.0m * (1 - 30.67%))
Current Ratio = 0.83 (Total Current Assets 3.70b / Total Current Liabilities 4.48b)
Debt / Equity = 1.78 (Debt 1.97b / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 2.13 (Net Debt 1.09b / EBITDA 511.6m)
Debt / FCF = 2.73 (Net Debt 1.09b / FCF TTM 399.8m)
Total Stockholder Equity = 1.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.74% (Net Income 198.9m / Total Assets 5.75b)
RoE = 19.20% (Net Income TTM 198.9m / Total Stockholder Equity 1.04b)
RoCE = 15.74% (EBIT 405.0m / Capital Employed (Equity 1.04b + L.T.Debt 1.54b))
RoIC = 9.75% (NOPAT 280.8m / Invested Capital 2.88b)
WACC = 6.73% (E(5.33b)/V(7.30b) * Re(7.50%) + D(1.97b)/V(7.30b) * Rd(6.70%) * (1-Tc(0.31)))
Discount Rate = 7.50% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -14.76 | Cagr: 0.10%
[DCF] Terminal Value 77.97% ; FCFF base≈377.7m ; Y1≈433.0m ; Y5≈637.2m
[DCF] Fair Price = 23.22 (EV 9.59b - Net Debt 1.09b = Equity 8.50b / Shares 366.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.62 | EPS CAGR: 22.49% | SUE: 0.89 | # QB: 1
Revenue Correlation: 97.08 | Revenue CAGR: 23.83% | SUE: 1.43 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.33 | Chg30d=-1.49% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.41 | Chg30d=-1.06% | Revisions=+0% | GrowthEPS=+19.1% | GrowthRev=+17.6%
EPS next Year (2027-12-31): EPS=1.57 | Chg30d=-2.48% | Revisions=+0% | GrowthEPS=+12.1% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: -12% (up=2, down=3)